Elbow Artery Embolization for Tennis Elbow

Launched by SIDDHARTH PADIA, MD · Apr 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment for tennis elbow, which is a condition that causes pain on the outside of the elbow. The researchers want to see if a procedure called elbow artery embolization (EAE) is safe and effective for relieving this pain. EAE uses a special device made of tiny particles, called Embozene, to block blood flow to the area causing the pain, which may help reduce inflammation and discomfort.

To be eligible for this study, participants should be between 18 and 80 years old and have been experiencing moderate to severe elbow pain for at least six months, despite trying other treatments like medications or physical therapy. Participants should also be able to understand the study and provide consent. If you join the study, you will receive this new treatment and be monitored closely by the research team. This trial is currently looking for volunteers, and it’s a chance to help find a potential new option for treating tennis elbow.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years and less than 80 years
• • Diagnosis of lateral epicondylitis based on history and physical exam
• • Ability to provide informed consent
• • Life expectancy greater than 12 months
• • Moderate-severe lateral elbow pain as determined by visual analog scale \> 4 (based on average severity during physical activity)
• • Resistant/failed conservative treatment (e.g. NSAIDS/physical therapy/steroid joint injection) for at least 6 months.
• Exclusion Criteria:
• • Mild elbow pain as determined by visual analog scale \< 4
• • Chronic renal insufficiency (serum creatinine \>2 mg/dL)
• • Allergy to iodinated contrast agents that is not responsive to steroid management
• • Active Infection or malignancy
• • Prior elbow surgery in the subject elbow
• • Uncorrectable bleeding diathesis